Bionano genomics announces presentations on optical genome mapping at the american association for cancer research (aacr) annual meeting 2021

San diego, april 07, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced that multiple studies on the detection of structural variants using bionano's optical genome mapping, including a spotlight presentation, will be presented at the american association for cancer research (aacr) annual meeting 2021, which is being held in a virtual format april 10-15, 2021.
BNGO Ratings Summary
BNGO Quant Ranking